These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 11898551)

  • 21. The role of tau phosphorylation and cleavage in neuronal cell death.
    Chun W; Johnson GV
    Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
    Strang KH; Golde TE; Giasson BI
    Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Spillantini MG; Van Swieten JC; Goedert M
    Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration.
    Kovacs GG; Majtenyi K; Spina S; Murrell JR; Gelpi E; Hoftberger R; Fraser G; Crowther RA; Goedert M; Budka H; Ghetti B
    J Neuropathol Exp Neurol; 2008 Oct; 67(10):963-75. PubMed ID: 18800011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.
    Zhukareva V; Vogelsberg-Ragaglia V; Van Deerlin VM; Bruce J; Shuck T; Grossman M; Clark CM; Arnold SE; Masliah E; Galasko D; Trojanowski JQ; Lee VM
    Ann Neurol; 2001 Feb; 49(2):165-75. PubMed ID: 11220736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontotemporal lobar degeneration--tau as a pied piper?
    Tolnay M; Probst A
    Neurogenetics; 2002 Oct; 4(2):63-75. PubMed ID: 12481984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations
    Bardai FH; Wang L; Mutreja Y; Yenjerla M; Gamblin TC; Feany MB
    J Neurosci; 2018 Jan; 38(1):108-119. PubMed ID: 29138281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration.
    Ling H
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.
    Goedert M; Ghetti B; Spillantini MG
    Ann N Y Acad Sci; 2000; 920():74-83. PubMed ID: 11193179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
    García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of tauopathies with transgenic mice.
    Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
    Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies.
    Zempel H
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):66-70. PubMed ID: 37795931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.
    Higuchi M; Zhang B; Forman MS; Yoshiyama Y; Trojanowski JQ; Lee VM
    J Neurosci; 2005 Oct; 25(41):9434-43. PubMed ID: 16221853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of tau isoform expression and dementia.
    D'Souza I; Schellenberg GD
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):104-15. PubMed ID: 15615630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy.
    Chiba S; Takada E; Tadokoro M; Taniguchi T; Kadoyama K; Takenokuchi M; Kato S; Suzuki N
    Neurobiol Aging; 2012 Oct; 33(10):2491-505. PubMed ID: 22169201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disentangling the role of the tau gene locus in sporadic tauopathies.
    Vandrovcova J; Anaya F; Kay V; Lees A; Hardy J; de Silva R
    Curr Alzheimer Res; 2010 Dec; 7(8):726-34. PubMed ID: 20704554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.